Vision and Creation of the American Heart Association Pharmaceutical Roundtable Outcomes Research Centers (original) (raw)

Priorities for Cardiovascular Outcomes Research: A Report of the National Heart, Lung, and Blood Institute's Centers for Cardiovascular Outcomes Research Working Group

Harlan Krumholz

Circulation. Cardiovascular quality and outcomes, 2017

View PDFchevron_right

Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease

Neil Powe

Circulation, 2005

View PDFchevron_right

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

James Tcheng

Circulation, 2014

View PDFchevron_right

Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov

David Kong

Journal of the American Heart Association, 2013

View PDFchevron_right

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

JENNIFER WHITE

American Heart Journal, 2013

View PDFchevron_right

Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology

Peter Mol

European heart journal, 2015

View PDFchevron_right

Multicenter Cardiovascular Studies and Trials: Lessons Learned From 35 Years of Productive Collaboration

Emanuela Locati

Journal of the American College of Cardiology, 2016

View PDFchevron_right

Lessons from overviews of cardiovascular trials

Curt Furberg

Statistics in Medicine, 1987

View PDFchevron_right

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group

Eberhard Standl

Cardiovascular Diabetology

View PDFchevron_right

Priorities for Comparative Effectiveness Reviews in Cardiovascular Disease

Gillian Sanders Schmidler

Circulation: Cardiovascular Quality and Outcomes, 2013

View PDFchevron_right

Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study

Estevão Figueiredo

Arquivos Brasileiros de Cardiologia, 2013

View PDFchevron_right

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

Karl Swedberg

2014

View PDFchevron_right

Are potentially clinically meaningful benefits misinterpreted in cardiovascular randomized trials? A systematic examination of statistical significance, clinical significance, and authors' conclusions

Michael Allan

BMC medicine, 2017

View PDFchevron_right

Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium

Judith Prochaska

American Heart Journal, 2015

View PDFchevron_right

Impactful Clinical Trials of 2012: What Clinicians Need to Know

Narendra Singh

Canadian Journal of Cardiology, 2013

View PDFchevron_right

Vascular Disease Quality of Care and Outcomes Research and Atherosclerotic Peripheral and Cardiovascular Nursing and the Interdisciplinary Working Groups on American Heart Association Councils on Epidemiology and Prevention, Stroke, Management of Heart Disease and Stroke: A Scientific Statement F...

Janet Croft

2007

View PDFchevron_right

Patient-Reported Outcomes in Cardiovascular Trials

Brittany Taylor

Canadian Journal of Cardiology, 2021

View PDFchevron_right

Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial

Rafael Marques Soares

American Heart Journal, 2019

View PDFchevron_right

Study design, result posting, and publication of late-stage cardiovascular trials

Elias Mossialos

European Heart Journal - Quality of Care and Clinical Outcomes, 2020

View PDFchevron_right

Phase II Clinical Research Design in Cardiology: Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Network (CCTRN)

Emerson Perin

Circulation, 2013

View PDFchevron_right

Clinical trials update from the American College of Cardiology 2008: Carisma, Trends, meta-analysis of Cox-2 studies, Hat, on-Target, Hyvet, Accomplish, Momentum, Protect, Horizon-hf and Reverse

Damien Cullington, Lwin Tin

European Journal of Heart Failure, 2008

View PDFchevron_right

Publication of Trials Funded by the National Heart, Lung, and Blood Institute

Wendy Taddei-Peters

New England Journal of Medicine, 2013

View PDFchevron_right

The HEART Pathway Randomized Controlled Trial One-year Outcomes

Bret Nicks

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2018

View PDFchevron_right

2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Wri...

Dan Fintel

Circulation, 2013

View PDFchevron_right

Identifying needs and opportunities for advancing translational research in cardiovascular disease

Frank Rademakers

Cardiovascular Research, 2009

View PDFchevron_right

Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011

Yasir Akram

Journal of the American Heart Association, 2017

View PDFchevron_right

The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials

Stefan Agewall

European Heart Journal - Cardiovascular Pharmacotherapy, 2019

View PDFchevron_right